Skip to main navigation Skip to search Skip to main content

CTU: A Multicentre, Phase II, Randomised, Open-label Study to Evaluate the Efficacy of Acalabrutinib in Combination with Venetoclax and Rituximab in Participants with Treatment Naïve Mantle Cell Lymphoma

  • Menzies Wojtowicz, Monique (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • Contacos, Christine (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleD822GC00001
AcronymTrAVeRse
StatusActive
Effective start/end date30/11/2313/11/28